✦ LIBER ✦

High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: A case series

✍ Scribed by Jeffrey Talbot; David A. Rizzieri; Carlos M. DeCastro; Joseph O. Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Brumbaugh; Jon P. Gockerman

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 263 KB
Volume: 73
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.10362

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone and high-dose etoposide for

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia

✍ Susan O'Brien; Kantarjian Hagop; Elihu Estey; Charles Koller; Miloslav Beran; Ke 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Mitoxantrone, etoposide, and cytarabine

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia : An Eastern Cooperative Oncology Group pilot study

✍ Martin S. Tallman; Sandra Lee; Branimir I. Sikic; Elisabeth Paietta; Peter H. Wi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: One potential mechanism of drug resistance to chemotherapy is the overexpression of multidrug resistance (mdr) genes coding for p-glycoprotein (p-gp), which leads to reduced intracellular retention of chemotherapy. this study tested the efficacy and toxicity of mitoxantrone, etoposid

High dose cyclophosphamide, BCNU, and VP

High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia

✍ Axel R. Zander; Steven Culbert; Sundar Jagannath; Gary Spitzer; Michael Keating; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 1 views

Reduced intensity compared with high dos

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: A comparative clinical analysis

✍ Catherine M. Flynn; Betsy Hirsch; Todd DeFor; Juliet N. Barker; Jeffrey S. Mille 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

High antileukemic activity of sequential

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias : Results of a clinical Phase II study

✍ Wolfgang Kern; Eberhard Schleyer; Michael Unterhalt; Bernhard Wörmann; Thomas Bü 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Department of Heremission whereas 5 patients (23%) succumbed to early death and 3 patients (14%) matology and Oncology, Go ¨ttingen, Germany. did not respond. Blood counts recovered at a median of 33.5 days after the start 2 Westfa ¨lische Wilhelms University, Department of treatment and complete r

Pharmacology of cytarabine given as a co

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia

✍ Fevzi Ozkaynak, M.; Avramis, Vassilios I.; Carcich, Sherri; Ortega, Jorge A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Background. The outcome of patients with acute myeloid leukemia (AML) who relapse or fail to achieve an initial remission has been dismal. Procedure. Fifteen pediatric patients with AML, 4 relapsed and 11 primary refractory, were reinduced with a loading bolus of 0.5 g/m 2 cytarabine (ara-C) followe